Furthermore, in advanced PCa, where treatments such as hormonal therapy, chemotherapy or immunotherapy may not completely eradicate the disease, PSA monitoring has been used to evaluate tumor response over time, determining treatment effectiveness, and deciding when to change therapy [18] (https://www.cancer.org/, accessed 21st June 2023). Here, KLK3 is linked to neoplasm.